Literature DB >> 25156132

Long term complications of polycystic ovary syndrome (PCOS).

Maëliss Peigné1, Didier Dewailly2.   

Abstract

Polycystic ovary syndrome (PCOS) is a frequent endocrine disease affecting 10 to 15% of women. Menstrual disorders, hyperandrogenism and ultrasonographic aspect of ovaries are typical of the disease and are established diagnostic criteria. But PCOS has also long term complications frequently forgotten and underestimated. During pregnancy, gestational diabetes and gestational hypertensive disorders can occur. At an older age, metabolic disease such as glucose intolerance, type 2 diabetes or dyslipidaemia are frequently described. Women with PCOS have increased classical cardiovascular risks and increased subclinical cardio-vascular disease without proven increase of cardiovascular morbidity and mortality. Finally, endometrial cancer seems to be more frequent in women with PCOS. Therefore, PCOS have numerous long-term health risks and a life-long follow-up is necessary for these women "at-risk" to detect and prevent complications as soon as possible.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cancer; Cardio-vascular disease; Complications; Health; PCOS; Pathologie cardio-vasculaire; SOPK; Santé

Mesh:

Year:  2014        PMID: 25156132     DOI: 10.1016/j.ando.2014.07.111

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  11 in total

1.  Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).

Authors:  Eleftherios P Diamandis; Frank Z Stanczyk; Sarah Wheeler; Anu Mathew; Martin Stengelin; Galina Nikolenko; Eli N Glezer; Marshall D Brown; Yingye Zheng; Yen-Hao Chen; Hsiao-Li Wu; Ricardo Azziz
Journal:  Clin Chem Lab Med       Date:  2017-10-26       Impact factor: 3.694

2.  Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome.

Authors:  Ying Yu; Panli Tan; Zhenchao Zhuang; Zhejiong Wang; Linchao Zhu; Ruyi Qiu; Huaxi Xu
Journal:  BMC Med Genomics       Date:  2021-08-20       Impact factor: 3.063

Review 3.  Mitochondrial Dysfunction in Obesity and Reproduction.

Authors:  Manasi Das; Consuelo Sauceda; Nicholas J G Webster
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 5.051

4.  Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.

Authors:  William Atiomo; Mohamad Nasir Shafiee; Caroline Chapman; Veronika M Metzler; Jad Abouzeid; Ayşe Latif; Amy Chadwick; Sarah Kitson; Vanitha N Sivalingam; Ian J Stratford; Catrin S Rutland; Jenny L Persson; Niels Ødum; Pablo Fuentes-Utrilla; Jennie N Jeyapalan; David M Heery; Emma J Crosbie; Nigel P Mongan
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-18       Impact factor: 3.478

Review 5.  Hypothalamic Inflammation as a Potential Pathophysiologic Basis for the Heterogeneity of Clinical, Hormonal, and Metabolic Presentation in PCOS.

Authors:  Danai Barlampa; Maria Sotiria Bompoula; Alexandra Bargiota; Sophia Kalantaridou; George Mastorakos; Georgios Valsamakis
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

6.  Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.

Authors:  Jingjing Liu; Qunhong Wu; Yanhua Hao; Mingli Jiao; Xing Wang; Shengchao Jiang; Liyuan Han
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

7.  Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Mohd Falihin Mohd Shukri; Mohd Noor Norhayati; Salziyan Badrin; Azidah Abdul Kadir
Journal:  PeerJ       Date:  2022-09-16       Impact factor: 3.061

Review 8.  Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome.

Authors:  Young-Mo Yang; Eun Joo Choi
Journal:  Ther Clin Risk Manag       Date:  2015-09-01       Impact factor: 2.423

9.  Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome.

Authors:  D Rama Nagendra Kumar; Krishna G Seshadri; Monna Pandurangi
Journal:  Indian J Endocrinol Metab       Date:  2017 Sep-Oct

10.  Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.

Authors:  Nasser A Dhayat; Nesa Marti; Zahraa Kollmann; Amineh Troendle; Lia Bally; Geneviève Escher; Michael Grössl; Daniel Ackermann; Belen Ponte; Menno Pruijm; Michael Müller; Bruno Vogt; Martin H Birkhäuser; Murielle Bochud; Christa E Flück
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.